Our findings revealed that targeting DNMT1 in oral cancer cells resulted in near-complete genome-wide DNA hypomethylation, triggering the dual attenuation of PI3K-AKT and CDK2-Rb and collaborative phosphorylation of GSK3β. The gene discussed is RB1; the disease is lip and oral cavity carcinoma.